Cargando…

Clinical application of clustered-AChR for the detection of SNMG

Myasthenia gravis (MG) is an autoantibody-mediated disease of the neuromuscular junction (NMJ). However, accumulating evidence has indicated that MG patients whose serum anti-acetylcholine receptor (AChR) antibodies are not detectable (serumnegative MG; SNMG) in routine assays share similar clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Guang, Wang, Xiaoqing, Yu, Xiaowen, Zhang, Xiutian, Guan, Yangtai, Jiang, Jianming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464178/ https://www.ncbi.nlm.nih.gov/pubmed/26068604 http://dx.doi.org/10.1038/srep10193

Ejemplares similares

A Stable Cell Line Expressing Clustered AChR: A Novel Cell-Based Assay for Anti-AChR Antibody Detection in Myasthenia Gravis
por: Cai, Yu, et al.
Publicado: (2021)

Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs
por: Cetin, Hakan, et al.
Publicado: (2020)

alpha-Actinin interacts with rapsyn in agrin-stimulated AChR clustering
por: Dobbins, G Clement, et al.
Publicado: (2008)

Protein Tyrosine Phosphatase Receptor Type R (PTPRR) Reduces AChR Clustering by Dephosphorylating MuSK
por: Chen, Yanxun, et al.
Publicado: (2022)

IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation
por: Cao, Michelangelo, et al.
Publicado: (2023)

HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions
por: Osseni, Alexis, et al.
Publicado: (2020)

PKC and PKA Regulate AChR Dynamics at the Neuromuscular Junction of Living Mice
por: Martinez-Pena y Valenzuela, Isabel, et al.
Publicado: (2013)

Impact of Key Nicotinic AChR Subunits on Post-Stroke Pneumococcal Pneumonia
por: Jagdmann, Sandra, et al.
Publicado: (2020)

Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis
por: Zhao, Rui, et al.
Publicado: (2021)

Site-directed MT1-MMP trafficking and surface insertion regulate AChR clustering and remodeling at developing NMJs
por: Chan, Zora Chui-Kuen, et al.
Publicado: (2020)

The Clinical Outcome in AChR-Positive Generalized Myasthenia Gravis: A Retrospective Observational Study
por: Ojha, Pawan T., et al.
Publicado: (2023)

Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses
Publicado: (1991)

AChR deficiency due to ε-subunit mutations: two common mutations in the Netherlands
por: Faber, Catharina G., et al.
Publicado: (2009)

Mutagenesis of the 43-kD postsynaptic protein defines domains involved in plasma membrane targeting and AChR clustering
Publicado: (1991)

Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis
por: Spagni, Gregorio, et al.
Publicado: (2022)

Grp94 Regulates the Recruitment of Aneural AChR Clusters for the Assembly of Postsynaptic Specializations by Modulating ADF/Cofilin Activity and Turnover
por: Chan, Zora Chui-Kuen, et al.
Publicado: (2020)

Agrin-induced reorganization of extracellular matrix components on cultured myotubes: relationship to AChR aggregation
Publicado: (1990)

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
por: Yilmaz, Vuslat, et al.
Publicado: (2015)

Compromised fidelity of B‐cell tolerance checkpoints in AChR and MuSK myasthenia gravis
por: Lee, Jae‐Yun, et al.
Publicado: (2016)

Plasma Myokine Profiles in Patients With AChR- and MuSK-Ab-Positive Myasthenia Gravis
por: Seok, Jo Woon, et al.
Publicado: (2023)

Clinical Outcomes in AchR Antibody-Positive Myasthenia Gravis: Where Does Rituximab Stand in the Current Times?
por: Dhamne, Megha Chetan
Publicado: (2023)

The Regulation Effect of α7nAChRs and M1AChRs on Inflammation and Immunity in Sepsis
por: Hu, Song, et al.
Publicado: (2021)

Tas2R activation relaxes airway smooth muscle by release of Gα(t) targeting on AChR signaling
por: Zhou, Yu-Wei, et al.
Publicado: (2022)

Temperature-sensitive expression of all-Torpedo and Torpedo-rat hybrid AChR in mammalian muscle cells
Publicado: (1990)

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
Publicado: (2015)

Correction: Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
Publicado: (2015)

Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
por: Saxena, Abhishek, et al.
Publicado: (2017)

Slow‐channel myasthenia due to novel mutation in M2 domain of AChR delta subunit
por: Shen, Xin‐Ming, et al.
Publicado: (2019)

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
por: Lupica, Antonino, et al.
Publicado: (2022)

Oral Microbiota Profile in a Group of Anti-AChR Antibody–Positive Myasthenia Gravis Patients
por: Huang, Chao, et al.
Publicado: (2022)

Impaired gating of γ‐ and ε‐AChR respectively causes Escobar syndrome and fast‐channel myasthenia
por: Shen, Xin‐Ming, et al.
Publicado: (2023)

AChRs Degeneration at NMJ in Aging-Associated Sarcopenia–A Systematic Review
por: Bao, Zhengyuan, et al.
Publicado: (2020)

The Association of PTPN22 R620W Polymorphism Is Stronger with Late-Onset AChR-Myasthenia Gravis in Turkey
por: Kaya, Gizem A., et al.
Publicado: (2014)

Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders
por: Clausen, Lisa, et al.
Publicado: (2018)

Improved resolution of single channel dwell times reveals mechanisms of binding, priming, and gating in muscle AChR
por: Mukhtasimova, Nuriya, et al.
Publicado: (2016)

AChR antibodies show a complex interaction with human skeletal muscle cells in a transcriptomic study
por: Hong, Yu, et al.
Publicado: (2020)

Autoantibody of NRIP, a novel AChR‐interacting protein, plays a detrimental role in myasthenia gravis
por: Tsai, Li‐Kai, et al.
Publicado: (2021)

Clinical Characteristics and Prognosis of Anti-AChR Positive Myasthenia Gravis Combined With Anti-LRP4 or Anti-Titin Antibody
por: Chen, Yuping, et al.
Publicado: (2022)

Selective cleavage of AChR cRNAs harbouring mutations underlying the slow channel myasthenic syndrome by hammerhead ribozymes
por: Abdelgany, Amr, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_v87ji08kiac7cuv7lfa2dmbsut